OTUD5, a member of the ovarian tumor domain (OTU) family of deubiquitinases, plays a pivotal role in cellular processes through its regulation of ubiquitin signaling. The primary function of OTUD5 is to remove ubiquitin moieties from protein substrates, thereby modulating their stability, localization, and activity. By selectively cleaving ubiquitin chains from target proteins, OTUD5 controls various cellular pathways, including DNA damage response, immune signaling, and protein turnover. Additionally, OTUD5 has been implicated in the regulation of key transcription factors and signaling molecules, highlighting its significance in diverse biological contexts.
Activation of OTUD5 involves intricate regulatory mechanisms that govern its enzymatic activity and substrate specificity. One of the primary modes of activation is post-translational modification, such as phosphorylation or ubiquitination, which can enhance or inhibit OTUD5 activity depending on the context. Additionally, binding partners and cellular localization play crucial roles in regulating OTUD5 function. For instance, interaction with specific protein complexes or subcellular localization to distinct cellular compartments may dictate OTUD5 substrate specificity and activity levels. Furthermore, upstream signaling pathways, such as those activated by cellular stress or cytokine stimulation, can influence OTUD5 expression and activity, thereby modulating its functional outcomes. Overall, elucidating the mechanisms of OTUD5 activation provides insights into the regulation of ubiquitin-mediated processes and their impact on cellular physiology and disease pathogenesis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
By inhibiting the proteasome, ubiquitinated proteins may accumulate, possibly influencing the activity of deubiquitinating enzymes like OTUD5. | ||||||
Ubiquitin E1 Inhibitor, PYR-41 | 418805-02-4 | sc-358737 | 25 mg | $360.00 | 4 | |
It could influence ubiquitin dynamics and potentially the activity of OTUD5. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
May affect phosphorylation states of proteins and thereby possibly influence OTUD5 interaction with substrates. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Alteration of phosphorylation states might influence substrate availability or interaction with OTUD5. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
By modifying the acetylation state of proteins, these might alter protein interactions and potentially affect OTUD5 activity indirectly. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Inducing DNA damage may activate pathways involving ubiquitination and deubiquitination processes, potentially affecting OTUD5. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR pathway has numerous substrates and its inhibition could potentially impact OTUD5 through alterations in cellular signaling. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
By altering cellular energy status and signaling, it might impact ubiquitination/deubiquitination dynamics. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Stress response modulation could influence protein folding and ubiquitination states, potentially impacting OTUD5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
By affecting cell survival and growth signaling pathways, they could potentially alter the activity of OTUD5. | ||||||